骨髓增生异常综合征患者铁代谢评估的影响因素:一项回顾性研究
该回顾性研究纳入181例MDS患者,采用MRI和(或)DECT检测肝、心铁浓度,分析铁代谢评估的影响因素。结果显示肝铁浓度与ASF正相关,心铁浓度与ASF无显著相关;输血依赖、EPO浓度及合并环状铁粒幼红细胞影响铁代谢。
要点
- MDS患者肝铁浓度与ASF正相关,心铁浓度与ASF无显著相关。
- 输血依赖显著影响肝和心铁浓度。
- 重度以上铁过载组EPO浓度明显高于轻中度铁过载组及正常组。
核心结论
- MDS患者肝铁浓度与ASF呈正相关,心铁浓度与ASF无明显相关性。
- 输血依赖、EPO浓度、合并环状铁粒幼红细胞是铁代谢的影响因素。
研究设计与样本
- 回顾性研究,纳入181例MDS患者,采用MRI和(或)DECT检测肝脏和心脏铁浓度。
- 其中41例患者在两次检查期间接受了规律铁螯合治疗。
- 同步检测ASF、EPO、心功能、肝转氨酶、肝炎抗体及外周血T细胞极化等指标,并收集骨髓纤维化、脾大、环孢素A使用等信息进行比较分析。
主要发现
- MRI组肝铁浓度与ASF正相关(r=0.512,P<0.001),DECT组肝铁浓度与ASF正相关(r=0.606,P<0.001)。
- MRI组心铁浓度与ASF仅呈弱相关(r=0.303,P<0.001),DECT组心铁浓度与ASF无明显相关性(r=0.231,P=0.053)。
- 输血依赖显著影响肝和心铁浓度:MRI组LIC(28.370±10.706)mg/g对(7.593±3.508)mg/g,t=24.30,P<0.001;MIC 1.81对0.95,z=2.625,P<0.05;DECT组肝VIC(4.269±1.258)g/L对(1.078±0.383)g/L,t=23.14,P<0.001;心VIC 1.69对0.68,z=3.142,P<0.05。
- 重度以上铁过载组EPO浓度明显高于轻中度铁过载组及正常组(P<0.001)。
- MDS-RS患者较其他MDS低危组肝铁浓度明显增高:DECT组3.80(1.97,5.51)g/L对1.66(0.67,2.94)g/L,P=0.004;MRI组13.7(8.1,29.1)mg/g对11.6(7.1,21.1)mg/g,P=0.032。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the influencing factors of iron metabolism assessment in patients with myelodysplastic syndrome. Methods: MRI and/or DECT were used to detect liver and cardiac iron content in 181 patients with MDS, among whom, 41 received regular iron chelation therapy during two examinations. The adjusted ferritin (ASF) , erythropoietin (EPO) , cardiac function, liver transaminase, hepatitis antibody, and peripheral blood T cell polarization were detected and the results of myelofibrosis, splenomegaly, and cyclosporine were collected and comparative analyzed in patients. Results: We observed a positive correlation between liver iron concentration and ASF both in the MRI group and DECT groups (r=0.512 and 0.606, respectively, P<0.001) , only a weak correlation between the heart iron concentration and ASF in the MRI group (r=0.303, P<0.001) , and no significant correlation between cardiac iron concentration and ASF in the DECT group (r=0.231, P=0.053) . Moreover, transfusion dependence in liver and cardiac [MRI group was significantly associated with the concentration of iron in: LIC: (28.370±10.706) mg/g vs (7.593±3.508) mg/g, t=24.30, P<0.001; MIC: 1.81 vs 0.95, z=2.625, P<0.05; DECT group: liver VIC: (4.269±1.258) g/L vs (1.078±0.383) g/L, t=23.14, P<0.001: cardiac VIC: 1.69 vs 0.68, z=3.142, P<0.05]. The concentration of EPO in the severe iron overload group was significantly higher than that in the mild to moderate iron overload group and normal group (P<0.001) . Compared to the low-risk MDS group, the liver iron concentration in patients with MDS with cyclic sideroblasts (MDS-RS) was significantly elevated [DECT group: 3.80 (1.97, 5.51) g/L vs 1.66 (0.67, 2.94) g/L, P=0.004; MRI group: 13.7 (8.1,29.1) mg/g vs 11.6 (7.1,21.1) mg/g, P=0.032]. Factors including age, bone marrow fibrosis, splenomegaly, T cell polarization, use of cyclosporine A, liver aminotransferase, and hepatitis antibody positive had no obvious effect on iron metabolism. Conclusion: There was a positive correlation between liver iron concentration and ASF in patients with MDS, whereas there was no significant correlation between cardiac iron concentration and ASF. Iron metabolism was affected by transfusion dependence, EPO concentration, and RS. 目的: 分析骨髓增生异常综合征(MDS)患者铁代谢评估的影响因素。 方法: 181例MDS患者接受磁共振成像(MRI)和(或)能谱CT(DECT)对肝脏和心脏铁浓度的检测,其中41例患者在2次检查期间接受了规律铁螯合治疗(ICT)。同步检测调整铁蛋白(ASF)、红细胞生成素(EPO)、心功能、肝转氨酶、肝炎抗体、外周血T细胞极化等指标,并收集患者是否合并骨髓纤维化、脾大、环孢素A使用等信息进行比较分析。 结果: MRI组、DECT组肝铁浓度均与ASF呈正相关(r分别为0.512、0.606,P值均<0.001),MRI组心铁浓度与ASF仅呈弱相关(r=0.303,P<0.001),而DECT组心铁浓度与ASF无明显相关性(r=0.231,P=0.053)。输血依赖显著影响患者肝和心铁浓度[MRI组:LIC:(28.370±10.706)mg/g对(7.593±3.508)mg/g,t=24.30,P<0.001;MIC:1.81对0.95,z=2.625,P<0.05,DECT组:肝VIC:(4.269±1.258)g/L对(1.078±0.383)g/L,t=23.14,P<0.001:心VIC:1.69对0.68,z=3.142,P<0.05]。重度以上铁过载组患者EPO浓度明显高于轻中度铁过载组及正常组(P值均<0.001);MDS伴环状铁粒幼红细胞(MDS-RS)患者与和其他MDS低危组患者相比,肝铁浓度明显增高[DECT组:3.80(1.97,5.51)g/L对1.66(0.67,2.94)g/L,P=0.004;MRI组:13.7(8.1,29.1)mg/g对11.6(7.1,21.1)mg/g,P=0.032]。而年龄、骨髓纤维化、脾大、T细胞极化、环孢素A的使用、肝转氨酶、肝炎抗体阳性等因素对铁代谢无明显影响。 结论: MDS患者肝铁浓度与ASF呈正相关,心铁浓度与ASF无明显相关性。输血依赖、EPO浓度、合并RS是铁代谢的影响因素。.
引用
- Zhang Y, Xiao C, Li J, et al. [Influencing factors of iron metabolism assessment in patients with myelodysplastic syndrome: A retrospective study]. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680627. doi:10.3760/cma.j.issn.0253-2727.2022.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。